- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Industry news
- Financings
News of the day
Sequenom Announces Pricing of Public Offering of Common Stock
SAN DIEGO--June 26, 2008--Sequenom, Inc. (NASDAQ:SQNM) today announced the pricing of its public offering of 5,500,000 shares of its common stock at a public offering price of $15.50 per share. All of the shares are being offered by Sequenom. The underwriters have a 30-day option to purchase up to an additional 825,000 shares of common stock. Sequenom expects the net proceeds from the offering to be used for the development of diagnostic tests for use on its MassARRAY(R) system and other... moreLuminex Corporation Announces Pricing of Public Offering of Common Stock
AUSTIN, Texas-- June 25, 2008--Luminex Corporation (NASDAQ:LMNX) announced today the pricing of its underwritten public offering of 3,500,000 shares of its common stock. The Company has granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock to cover over-allotments, if any. The offering is expected to close on June 30, 2008. moreBioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
BELLEVILLE, ON, June 25, 2008 - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has secured an amendment to a pre-existing $7.6 million contribution agreement with the Industrial Technologies Office of Industry Canada that will support the scale-up of its vaccine production facility in Belleville, Ontario. The amended agreement extends the timeline for completion of work on the production scale-up to March... moreIndustry news search
Most Viewed News
- Promise of Vical's CMV Vaccine Noted by Independent Experts
- ViRexx Announces $1,000,000 Financing and Standby Purchaser for Rights Offering to Shareholders
- ProMetic Life Sciences Inc. raises C$5 M
- CryoCath Announces Exercise of Over-Allotment Option
- GENVEC COMPLETES $17 MILLION REGISTERED DIRECT OFFERING
- RSS Feed...
Recent news
To keep up to date with news from this category use our
StemCells, Inc. Files Replacement Shelf Registration Statement
PALO ALTO, Calif. June 25, 2008 - StemCells, Inc. (NASDAQ: STEM) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared...
DiaMedica is to raise approximately $2.0 million
WINNIPEG, Manitoba - June 24, 2008 - DiaMedica Inc. (TSX-V:DMA) ("DiaMedica" or the "Company"), a drug discovery and development company focused on novel treatments for Type 2 diabetes, today announced that it has filed...
MedMira Completes Settlement of Debt
Halifax, Nova Scotia, June 24, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostics, announced today that it has reached an agreement with various debt...
SONIC INNOVATIONS ANNOUNCES LOAN AMENDMENT WITH GERMAN BANK
Salt Lake City-June 20, 2008-Sonic Innovations, Inc. (NASDAQ: SNCI), the only U.S.-based publicly traded manufacturer of digital hearing aids, announced today that the company's German subsidiary successfully negotiated...
Tripep - Financial update
June 17, 2008 -- In January 2008 Tripep finalized a rights offering which raised almost SEK 16 m. Since one of the guarantors, Rutger Smith, did not fulfill his commitment, the rights issue was SEK 8 m less than...
Purchase of shares by utilization of warrants
June 17, 2008 -- In addition to the announcement of June, 16 2008, primary insider Ørn Stuge (consultant for the board) has utilized his warrants and bought 30,000 shares at a rate of DKK 9.00 corresponding to the...
DURECT's Convertible Notes Exchange into Equity at Maturity
CUPERTINO, CA, June 17, 2008--DURECT Corporation (Nasdaq: DRRX) announced today that the remaining $23.6 million in 6.25% Convertible Notes had been exchanged by the holders at their maturity date into approximately 7.5...
VALEANT PHARMACEUTICALS ANNOUNCES INCREASE IN SHARE REPURCHASE AUTHORIZATION
ALISO VIEJO, Calif., June 17, 2008 - Valeant Pharmaceuticals International (NYSE: VRX) today announced that its board of directors has authorized the repurchase of an additional $100 million of its outstanding common...
Proposed Bonus Share Issue to double number of shares in issue
Dublin, Ireland, June 17, 2008 - ICON plc (NASDAQ:ICLR) (ISIN: IE0001827041), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that...
Consort Medical Plc Additional Listing - Blocklisting
June 17, 2008--A block listing application has been made by Consort Medical plc (the 'Company') a leader in medical devices for inhaled drug delivery and anaesthesia, for 150,000 ordinary shares of 10p each in the...
Increase of share capital
June 16, 2008 -- Reference is made to our Press Release of today June 16, 2008 regarding utilization of warrants (MediCult`s warrants programme of 2004 issued on April 15, 2004 and September 24, 2004 by the Board of...
Purchase of Shares by Utilization of Warrants
June 16, 2008 -- The primary insiders have utilized their warrants and have bought the shares on June 16, 2008 at a rate of DKK 9.00 corresponding to the market price of the MEC shares on the date of issuance of the...
Luminex Corporation Announces Public Offering of Common Stock
AUSTIN, Texas-- June 16, 2008--Luminex Corporation (NASDAQ:LMNX) announced today that it is commencing an underwritten public offering of 3,500,000 shares of its common stock. The Company expects to grant the...
Chemokine Therapeutics Closes $885,000 Offering
Vancouver, BC (June 16th, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases,...
BioSyntech Announces $10 Million Bought Deal Financing
Laval, Québec, June 16, 2008 -- BioSyntech, Inc. (TSX: BSY) today announced that it has entered into a bought deal agreement with Dundee Securities Corporation as lead underwriter pursuant to which Dundee has agreed to...
AkzoNobel Share Buyback Program
June 16,2008- AkzoNobel (Euronext Amsterdam: AKZ) has announced that, in line with the launch of its EUR1 billion share buyback program on March 17, 2008, the company has repurchased 1,603,140 ordinary shares in the...
MIV Board Approves One-For-10 Reverse Stock Split
ATLANTA (June 16, 2008) - MIV Therapeutics, Inc. (OTC/BB: MIVT) (Frankfurt: MIV), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable...
Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
MONTREAL, June 16, 2008 - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, announces that it has...
Exactech Signs New $40 Million Revolving Line of Credit
June 16, 2008 -- GAINESVILLE, Fla. -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has signed a...
Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
SEATTLE, June 16, 2008 -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced the Company has repaid the remaining balance, including accrued interest, of its 2008 Convertible Notes which reached...
Lorus Therapeutics Announces Rights Offering to Shareholders
TORONTO, CANADA - June 13, 2008 - Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and...
Reduction of the share capital and status of holding of own shares
June 13, 2008 -- At Novo Nordisk's ordinary general meeting on 12 March 2008 it was decided to reduce the company's B share capital from DKK 539,472,800 to DKK 526,512,800 by cancellation of part of the company's...
Biovail Provides Update on Share Repurchase Program
TORONTO--June 13, 2008--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that, as of June 12, 2008, the Company has purchased over 1,000,000 of its common shares under its previously announced share repurchase...
MERGE HEALTHCARE ANNOUNCES REDEMPTION OF RIGHTS UNDER SHAREHOLDER RIGHTS PLAN
Milwaukee , WI , June 12, 2008 - Merge Healthcare Incorporated (NASDAQ: MRGE; TSX: MRG), a medical imaging software and services company, announced that its Board of Directors has approved the redemption of all...
GENVEC COMPLETES $17 MILLION REGISTERED DIRECT OFFERING
GAITHERSBURG, MD - June 12, 2008 - GenVec, Inc. (Nasdaq: GNVC) has successfully completed its previously announced registered direct offering of 11,258,279 shares of its common stock and warrants to purchase 2,251,653...
Active Biotech's new issue fully subscribed
Lund, June 12, 2008-Active Biotech's new issue with preferential rights for the company's shareholders has been completed. Nordstjernan AB and MGA Holding AB subscribed for their respective preferential part of the new...
Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
SEATTLE, June 12 -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) today announced that a single institutional investor has agreed to purchase, for $23 million, newly issued 15% Convertible Senior Notes due 2011, with...
Novartis recommends rejection of ''mini-tender'' offer by TRC Capital for American Depositary Shares
Basel, June 12, 2008 - Novartis has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation, a private Canadian investment company that is offering to purchase up to two million American...
Issue of Equity
June 11, 2008 - The Company announces that application has been made for the admission to trading on AIM of 7,357,142 Ordinary Shares of 0.1p nominal value. Admission is expected to take place on 13 June 2008.
Notice on the Allotment of Stock Compensation-Type Stock Options (Stock Acquisition Rights)
June 11, 2008-Please be informed that Asahi Glass Co., Ltd. ("the Company") reached the decision at its meeting of the Board of Directors on June 11, 2008, to establish the following terms and conditions regarding the...
Placement of Preferred Stock Series A - US$ 3.6 million finance for clinical trials
Irvine, CA, June 11, 2008 - Proteo, Inc. (OTCBB: PTEO; Frankfurter Freiverkehr: WKN: 925981) announced today the placement of preferred stock.
Rohm and Haas Company Completes $1 Billion Accelerated Share Repurchase
PHILADELPHIA-- June 11, 2008 -- Rohm and Haas Company (NYSE:ROH) announced today that it has completed its Accelerated Share Repurchase program announced on September 10, 2007. The company completed the program on June...
Exiqon A/S increases its share capital in connection with exercise of warrants
Exiqon A/S has today 11 June 2008 completed an increase of its share capital by DKK 1,456, nominal value, as a result of an exercise of warrants.
Ipsogen announces the success of the offer that ended on 9 June 2008 and its listing on Alternext
Luminy, 10 June, 2008 - IPSOGEN (Alternext - FR0010626028 - ALIPS), a pioneer and key player in the development and marketing of molecular diagnostic tests for cancer, announces the success of the offer that ended on 9...
PCI Biotech raises NOK 60 million in offering
Oslo, 10 June 2008. PCI Biotech Holding ASA, the Norwegian drug delivery company with a focus on cancer therapeutics, today announced the successful closing of its initial public offering in connection with the listing...
Withdrawal of S-1
EMERYVILLE, California and BRISBANE, Australia, 10 June 2008: Peplin, Inc. (ASX:PLI) today announced that it had withdrawn its registration statement on Form S-1 and will pursue alternative financing options.
Aspect Medical Systems Repurchases $10 Million of Its 2.5% Convertible Senior Notes Due 2014
NORWOOD, Mass.--June 10, 2008--Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that it has repurchased, in privately negotiated transactions, an aggregate of approximately $10 million face value of its 2.5%...
Novartis successfully issues two Swiss franc benchmark bonds totaling CHF 1.5 billion
Basel, June 10, 2008 - Novartis has successfully issued two Swiss franc benchmark bonds totaling CHF 1.5 billion in the Swiss capital market, marking the first time ever that Novartis has issued a bond in this currency.
Merrimack Pharmaceuticals Raises $60 Million in Private Financing
CAMBRIDGE, Mass., June 10, 2008 - Merrimack Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of novel treatments for autoimmune disease and cancer, today announced that it has...
PCI Biotech raises NOK 60 million in offering
Oslo, 10 June 2008. PCI Biotech Holding ASA, the Norwegian drug delivery company with a focus on cancer therapeutics, today announced the successful closing of its initial public offering in connection with the listing...
MedMira Announces Draw Down of Equity Line
Halifax, Nova Scotia, June 10, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions, announces its intention to enter into an arrangement for a...
BioForce Nanosciences Completes Financing
AMES, IA, June 10, 2008 -- BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH), a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced the...
iCo Therapeutics Closes $1,140,450 Financing
June 9, 2008 -- VANCOUVER, Canada - iCo Therapeutics Inc. (TSX-V: ICO) announced today that it has closed a non-brokered private placement to raise gross proceeds of $1,140,450 through the issuance of 3,801,500 common...
Genta Announces First Closing of its $40 Million Convertible Financing Facility; Issues $20 Million in Senior Secured Convertible Notes
BERKELEY HEIGHTS, NJ - June 9, 2008 - Genta Incorporated (OTCBB: GNTA) announced today that the Company has issued $20 million of Senior Secured Convertible Notes due 2010. Holders of the Notes shall have the right, but...
Novo Nordisk A/S - Share repurchase programme
June 09, 2008 -- On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as...
DIAMYD'S WARRANT IS LISTED FOR TRADING ON FIRST NORTH
Stockholm, June 9, 2008--Diamyd Medical AB (publ.) executed a direct placement on April 18th 2008, where each issued new share was accompanied by a one year warrant with a subscription price of SEK 100. These warrants...
GENFIT SECURES EUR7.1 MILLION FUNDING FROM OSEO AS PART OF THE IT-DIAB PROGRAM
Lille (France), Cambridge (Massachusetts, United States), June 9, 2008 - GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of research and development of cardiovascular,...
AkzoNobel Share Buyback Program (Week 23 of 2008)
June 9, 2008 - AkzoNobel (Euronext Amsterdam: AKZ) has announced that, in line with the launch of its EUR1 billion share buyback program on March 17, 2008, the company has repurchased 1,353,500 ordinary shares in the...
Creabilis Therapeutics Raises EUR20 Million in a Series A Funding Led by Sofinnova Partners and in Collaboration with NeoMed
Ivrea, Italy - 6th June, 2008 - Creabilis Therapeutics SpA, an emerging specialty pharmaceutical company focused on dermatology, today announces that it has raised a total of EUR20 million in a Series A round of...
GENVEC ANNOUNCES REGISTERED OFFERING OF $17 MILLION IN COMMON STOCK AND WARRANTS
GAITHERSBURG, MD - June 6, 2008 - GenVec, Inc. (Nasdaq: GNVC) announced today that it has entered into purchase agreements with certain current and new institutional and accredited investors for the sale of 11,258,279...
CryoCath Closes Exercise of Over-Allotment Option
Montreal, Canada, June 6, 2008 - CryoCath Technologies Inc. (TSX: CYT), today announced that it has closed the previously announced partial exercise by the underwriters of the over-allotment option granted to them in...
American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
NEW YORK, June 5 -- American Oriental Bioengineering (NYSE: AOB) announced today that it has withdrawn its convertible preferred stock offering. The decision to cancel its convertible preferred stock offering at this...
ViRexx Announces $1,000,000 Financing and Standby Purchaser for Rights Offering to Shareholders
EDMONTON, ALBERTA - June 5, 2008 - ViRexx Medical Corp. ("ViRexx" or the "Corporation") (TSX:VIR) (AMEX:REX) today announced that it has entered into a Standby Purchase Agreement ("Agreement") dated May 22, 2008,...
Promise of Vical's CMV Vaccine Noted by Independent Experts
SAN DIEGO, June 5, 2008 -- In an editorial commentary(1) in the current issue of The Journal of Infectious Diseases (JID), independent experts on cytomegalovirus (CMV) said the vaccine under development by Vical...
CryoCath Announces Exercise of Over-Allotment Option
Montreal, Canada, June 5, 2008 - CryoCath Technologies Inc. (TSX: CYT), today announced that the underwriters have exercised in part the over-allotment option granted to them in connection with CryoCath's recent bought...
Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
BERKELEY HEIGHTS, NJ - June 5, 2008 - Genta Incorporated (OTCBB: GNTA) announced today that the Company has entered into definitive agreements with institutional and accredited investors to place Senior Secured...
Exelixis Receives $150 Million Funding Commitment From Deerfield Management
SOUTH SAN FRANCISCO, Calif., June 5, 2008 -- Exelixis, Inc. (Nasdaq: EXEL) announced today that the company has entered into an agreement with Deerfield Management, a leading healthcare investment organization and...
ViroGates Fully Subscribes New Financing Round
June 4, 2008 -- ViroGates announced today that it has closed a private financing round of DKK 15 million as new equity capital. Current shareholders and three new private investors subscribed the amount, which will...
Grant of Warrants in Genmab A/S
Copenhagen, Denmark; June 04, 2008 - Genmab A/S (OMX: GEN) announced today that on a board meeting the board decided to issue 231,500 warrants to employees of the company as well as the company's subsidiaries and to a...
MERGE HEALTHCARE ANNOUNCES SUCCESSFUL COMPLETION OF $20 MILLION FINANCING
Milwaukee, WI, June 4, 2008 - Merge Healthcare Incorporated (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, announced today the successful completion of its $20 million financing...
MedMira Closes $1 Million Institutional Investment
Halifax, Nova Scotia, June 4, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions, announced today that it has received final approval from...
Zila Takes Steps to Clear Path for Growth and Financial Stability
PHOENIX --- June 4, 2008--Zila, Inc. (NASDAQ:ZILA) today said it has revised its agreement with the holders of its senior secured convertible notes to modify the EBITDA and minimum cash balance covenants.
American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock
NEW YORK, June 3 -- American Oriental Bioengineering (NYSE: AOB) today announced that it plans to make a private offer, subject to market conditions and other factors, to sell approximately $125 million in aggregate...
The Medicines Company Announces Option Grants under NASDAQ Marketplace Rule 4350
PARSIPPANY, N.J., June 03, 2008 -- The Medicines Company (NASDAQ: MDCO) announced today that in accordance with NASDAQ Marketplace Rule 4350, the Company issued new inducement stock options to three executive and...
BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
LYNBROOK, N.Y., June 3 -- BioSpecifics Technologies Corp. (OTC Bulletin Board: BSTC.OB - News) today announced that it sold 100,000 unregistered shares of its common stock priced at $13 per share with aggregate proceeds...
IRX Therapeutics Completes $25 Million Series A Preferred Stock Offering
New York, June 3, 2008 -- IRX Therapeutics, a privately-held company dedicated to the discovery and development of proprietary drugs for the treatment of cancer and viral diseases, today announced that it has raised $25...
IsoRay Inc. Announces Authorization of Stock Repurchase Plan
Richland, Washington (June 3, 2008) ... IsoRay Inc. (AMEX:ISR), a medical isotope company focused on the treatment of prostate cancer and other malignant disease through use of its proprietary radioisotope technology,...
ProMetic Life Sciences Inc. raises C$5 M
June 3, 2008 - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces today that it has raised C$5 M in share capital.
Proposed rights issue
3 June 2008: The Board of Directors of NorDiag ASA has today resolved to propose to the general meeting a rights issue of minimum 15,000,000 and maximum 25,002,457 new shares at a subscription price of NOK 2 per share....
American Oriental Bioengineering Announces US$75 Million Share Repurchase Program
NEW YORK, June 2 -- American Oriental Bioengineering (NYSE: AOB) today announced that its Board of Directors has authorized a share repurchase program for the repurchase of up to $75 million of the Company's outstanding...
Ipsogen's Initial Public Offering on Alternext
Luminy, June 2, 2008 - IPSOGEN (Alternext - FR0010626028 - ALIPS), a pioneer and key player in the development and marketing of molecular diagnostic tests for cancer, announces that the Autorité de marchés financiers...
iCo Therapeutics Announces $1,140,450 Financing
June 2, 2008 -- VANCOUVER, Canada - iCo Therapeutics Inc. (TSX-V: ICO) announced today that it intends to complete a non-brokered private placement to raise gross proceeds of $1,140,450 through the issuance of 3,801,500...
Share Purchase Plan
June 02, 2008 - The Company was informed on 02 June 2008 that as a result of transactions on 02 June 2008 by the SkyePharma PLC Share Purchase Plan (an approved all employee share purchase plan) the Trustees of the Plan...
AkzoNobel Share Buyback Program (Week 22 of 2008)
June 2, 2008 -AkzoNobel has announced that, in line with the launch of its EUR1 billion share buyback program on March 17, 2008, the company has repurchased 570,000 ordinary shares in the period May 26 until May 30,...
Tripep executes a reverse stock split
May 27, 2008 -- In accordance with the resolution by the annual general meeting, Tripep will carry out a reverse stock split whereby ten (10) shares are consolidated into one (1) share.
Discovery Labs Secures $60 Million Committed Equity Financing Facility
Warrington, PA -- May 27, 2008 -- Discovery Laboratories, Inc. (Nasdaq: DSCO), has entered into a new Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a private investment group, in which...
NuSep Cancels the Converting Note issue and Announces a Share Purchase Plan
SYDNEY, AUSTRALIA - 26 May, 2008 - NuSep (ASX: NSP) wishes to advise the market that as a result of recent shareholder feedback the Board has decided to cancel the 14% Converting Note issue and withdraw the Prospectus...
Grifols obtains syndicated financing for 350 million euros
May 26, 2008 -- Grifols, a Spanish holding company specialising in the pharmaceutical-hospital industry and a world leader in the production of plasma derivatives, has signed a 350 million euro, long-term (five years),...
CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million
BRANFORD, Conn., May 22, 2008 -- CuraGen Corporation (Nasdaq: CRGN) announced today the completion of a series of privately negotiated transactions in which the Company sold the 5,000,000 shares of TopoTarget common...
Isis Files S-3 Registration Statement
CARLSBAD, Calif., May 21, 2008 -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that it has filed a registration statement on Form S-3 with the Securities and Exchange Commission relating to the registration...
Succession Plan
LONDON, UK, 21 May 2008 - At its Annual General Meeting later today, SkyePharma PLC (LSE: SKP) will announce that its Chief Executive Officer, Frank Condella, intends to step down from his executive position once the...
Welichem announces arrangement of non-brokered private placement
BURNABY, BC, May 20, 2008 - Welichem Biotech Inc. (the "Company") (TSX-V: WBI - News), is pleased to announce that it has arranged a non-brokered private placement of up to 100,000,000 Units at a purchase price of $0.05...
Warnex Completes its Debt Restructuring
Laval, QC, May 20, 2008 - Warnex Inc. (TSX: WNX) ("Warnex") is pleased to announce that it has closed its previously announced debt restructuring pursuant to which it had entered into agreements with the various holders...
Chindex International Announces Shelf Registration, Related Strategy And Guidance
BETHESDA, MARYLAND - May 13, 2008 - Chindex International, Inc. (NASDAQ: CHDX), a leading independent American provider of Western healthcare services and products in the People's Republic of China, announced that it...
XOMA Refinances Royalty-Based Loan Facility for $55 Million
BERKELEY, Calif., May 12, 2008 -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that it has entered into an amended loan facility under which it has...
Trading Update and Fund Raising
May 07, 2008--Cobra Biomanufacturing Plc (AIM:CBF), the international manufacturer of biopharmaceuticals provides a trading update following the completion of the first six months of its financial year to 31 March 2008...
Intrexon Corporation Secures $25 Million Series C-2 Investment.
May 7, 2008 -- BLACKSBURG VA: Intrexon Corporation, a privately held life sciences company focused on biotherapeutic control systems, announced today it has closed a $25 million Series C-2 financing by New River...
Announcement on Acquisition of the Company's Own Shares
April 14, 2008 -- Ono Pharmaceutical Co., Ltd. announced that it resolved an acquisition of its own shares pursuant to article 156 of the Corporate Law of Japan which is applicable in accordance with Article 165 (3) of...
BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
LYNBROOK, N.Y., Feb. 5 -- BioSpecifics Technologies Corp. (OTC Bulletin Board: BSTC - News) announced today that it has received full repayment of the loan owed to it by its former CEO, Edwin H. Wegman, who passed away...
CONVERTIBLE NOTE EXTENDED
December 21, 2007 - Norwood Abbey Ltd (ASX: NAL) advises that agreement has been reached to extend until March 26 2008 the $350,000 convertible note issued in September 2007. The note continues to be on the same terms...
Paraytec announces closing of £500,000 third round equity fundraising
8 December 2007 --York, UK-based scientific instrument company, Paraytec Ltd announced it has recently completed its third equity funding round. The £500,000 investment was raised from contributions from the Viking...
CONVERTIBLE NOTE EXTENDED
December 07, 2007 -- Norwood Abbey Ltd (ASX: NAL) advises that agreement has been reached to extend until March 26, 2007 the $350,000 convertible note issued in September 2007. The note continues to be on the same terms...
Duska Therapeutics Completes $5.75 Million Private Equity Financing
BALA CYNWYD, PA--Oct 1, 2007 -- Duska Therapeutics, Inc. ("Duska" or the "Company") (OTC BB:DSKA.OB - News), a biopharmaceutical company developing new medicines to treat cardiovascular disease, announced today that it...
$3.3 MILLION RIGHTS ISSUE
September 21, 2007 -- Medical technologies group Norwood Abbey Ltd [NAL:ASX] advises that it will undertake an underwritten renounceable rights issue to raise approximately $3.3 million.
EQUITY LINE DRAWDOWN
July 20, 2007 -- Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that it has initiated a further drawdown under its long-standing A$20 million equity line with Global Emerging Markets Inc. designed to...
CONSUMERS WELCOME RELIEF FROM ACNE; THERMACLEAR GAINS MARKET ACCEPTANCE
San Francisco, Calif. May 16, 2007 - Following the successful launch of its ThermaClear acne treatment device, Therative today announced it has closed an additional round of financing. Leading the round was new investor...
Conatus Pharmaceuticals completes second closing of $27.5 million private placement financing
SAN DIEGO, May 09, 2007 -- Conatus Pharmaceuticals Inc. today completed the $22 million second closing of the $27.5 million Series A Preferred Stock private placement announced in January this year. This closing is...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us